Skip to content

The role of the TGF-ß/Smads signaling pathway in the osteogenic degeneration of cervical intervertebral disc in patients with cervical spondylosis undergoing surgical treatment

The role of the TGF-ß/Smads signaling pathway in the osteogenic degeneration of cervical intervertebral disc in patients with cervical spondylosis undergoing surgical treatment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025180
Enrollment
Unknown
Registered
2019-08-15
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteogenic degeneration of the cervical intervertebral disc

Interventions

Sponsors

Dongzhimen Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed as cervical spondylosis based on clinical and radiological evidence. 2. Surgery for the first time was performed after at least 6 weeks conservative treatment, which was ineffective; 3. The surgical methods were either artificial cervical disc replacement (ACDR) or anterior cervical discectomy and fusion (ACDF).

Exclusion criteria

Exclusion criteria: 1. The cervical degeneration was serious, and the loss of intervertebral height was more than 80% of the adjacent normal segments. 2. Sufficient disc samples could not be obtained during operation. 3. Operative contraindications were found, such as poor cardiopulmonary function and intolerance to the surgery. 4. The patient had a history of neck injury or related surgery. 5. There was active hemorrhage or infection history of the patient. 6. There was a history of fracture, tumor, tuberculosis and other tissue-invasive diseases in the cervical spine.

Design outcomes

Primary

MeasureTime frame
TGF-ß1;p-Smad2;p-Smad3;

Countries

China

Contacts

Public ContactXing Yu

Dongzhimen Hospital, Beijing University of Chinese Medicine

yuxing34163@163.com+86 13701376079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026